These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15828618

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages.
    Dargent-Molina P, Piault S, Bréart G.
    Maturitas; 2006 Apr 20; 54(1):55-64. PubMed ID: 16202546
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Osteoporosis: whom, when and how to treat?].
    Stepán J.
    Cas Lek Cesk; 2009 Apr 20; 148(1):25-33. PubMed ID: 19634279
    [Abstract] [Full Text] [Related]

  • 29. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
    Rasheed A, Khurshid R, Aftab L.
    J Ayub Med Coll Abbottabad; 2008 Apr 20; 20(1):48-51. PubMed ID: 19024185
    [Abstract] [Full Text] [Related]

  • 30. Prevention and treatment of senile osteoporosis and hip fractures.
    Duque G, Demontiero O, Troen BR.
    Minerva Med; 2009 Feb 20; 100(1):79-94. PubMed ID: 19277006
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical risk factors and evaluation of the risk of osteoporosis in clinical practice.
    McClung MR.
    Ann Med Interne (Paris); 2000 Sep 20; 151(5):392-8. PubMed ID: 11033474
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of biochemical markers in the management of osteoporosis.
    Ebeling PR, Akesson K.
    Best Pract Res Clin Rheumatol; 2001 Jul 20; 15(3):385-400. PubMed ID: 11485336
    [Abstract] [Full Text] [Related]

  • 36. Risk factors and prevention of osteoporosis-related fractures.
    Dontas IA, Yiannakopoulos CK.
    J Musculoskelet Neuronal Interact; 2007 Jul 20; 7(3):268-72. PubMed ID: 17947811
    [Abstract] [Full Text] [Related]

  • 37. Fighting the fracture cascade: evaluation and management of osteoporotic fractures.
    Sack F.
    Postgrad Med; 2008 Nov 20; 120(4):51-7. PubMed ID: 19020365
    [Abstract] [Full Text] [Related]

  • 38. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
    Woitge HW, Seibel MJ.
    Clin Lab Med; 2000 Sep 20; 20(3):503-25, vi. PubMed ID: 10986618
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of postmenopausal osteoporosis].
    Chapurlat R, Delmas PD.
    Rev Prat; 2004 Dec 15; 54(19):2120-6. PubMed ID: 15724589
    [Abstract] [Full Text] [Related]

  • 40. The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk.
    Clowes JA, Eastell R.
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun 15; 14(2):213-32. PubMed ID: 11035903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.